|
FY2025
12 months to Dec 31, 2025
|
FY2023
3 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net loss | ||||
| Total net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities | ||||
| Depreciation and amortization | ||||
| Total depreciation and amortization | ||||
| Amortization of intangible assets | ||||
| Total amortization of intangible assets | ||||
| Amortization of right of use asset | ||||
| Total amortization of right of use asset | ||||
| Accrued interest expense on promissory note and convertible debt | ||||
| Deferred income taxes | ||||
| Stock-based compensation expense | ||||
| (Gain) loss on foreign currency transactions | ||||
| Loss on debt extinguishment | ||||
| Change in fair value of derivative liability | ||||
| (Gain) loss on contract to issue common stock | ||||
| Loss on asset disposal | ||||
| Impairment of goodwill | ||||
| Total impairment of goodwill | ||||
| Gain on debt settlement | ||||
| Change in operating assets and liabilities: | ||||
| Accounts receivable and other receivables | ||||
| Total accounts receivable and other receivables | ||||
| Prepaid expenses and other current assets | ||||
| Total prepaid expenses and other current assets | ||||
| Other assets | ||||
| Accounts payable | ||||
| Total accounts payable | ||||
| Accrued liabilities | ||||
| Total accrued liabilities | ||||
| Operating lease liabilities | ||||
| Total operating lease liabilities | ||||
| Deferred revenue | ||||
| Total deferred revenue | ||||
| Net cash used in operating activities | ||||
| Total net cash used in operating activities | ||||
| Investing activities | ||||
| Purchases of property and equipment | ||||
| Total purchases of property and equipment | ||||
| Net cash used in investing activities | ||||
| Total net cash used in investing activities | ||||
| Proceeds from issuance of convertible debt, net of issuance costs | ||||
| Proceeds from at-the-market offering, net of issuance cost | ||||
| Net cash provided by financing activities | ||||
| Total net cash provided by financing activities | ||||
| Effect of exchange rate changes on cash and cash equivalents | ||||
| Total effect of exchange rate changes on cash and cash equivalents | ||||
| Net increase (decrease) in cash and cash equivalents | ||||
| Total net increase (decrease) in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of Year | ||||
| Successor | ||||
| Total cash and cash equivalents, beginning of Year | ||||
| Cash and cash equivalents, end of year | ||||
| Successor | ||||
| Total cash and cash equivalents, end of year | ||||
| Supplemental schedule of noncash investing and financing activities | ||||
| Financing of Directors and Officers Insurance | ||||
| Common shares issued for debt extinguishment | ||||
| Common shares issued as commitment shares | ||||
| Right of use asset obtained in exchange for lease liability | ||||
Loading...